Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)

8.33 -0.26 (-3.03%) At close: 03:04PM CST

Guiyang Xintian Pharmaceutical Co.,Ltd.

No. 3 Gaoxin North Road, Wudang District
Guiyang 550000
China

https://www.gyxtyy.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 1,958

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Da Lun Dong	GM & Chairman of the Board	N/A	N/A	1964
Ms. Zhihui Zeng	Chief Financial Officer	N/A	N/A	1973
Mr. Jin Hua Wang	Deputy GM & Director	N/A	N/A	1967
Mr. Guangping Wang	Director & Deputy General Manager and Board Secretary	N/A	N/A	1970

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of new Chinese patent medicines for various diseases in China. The company offers formulation products, which include hard capsules, granules, tablets, mixtures, syrups, liquors, dews, powders, suspensions, and gels. Its products are used for the treatment of anti-tumor, gynecological, urological diseases, breast thyroid, blood supplement, heat clearing type, oral, anti-cold, and cardiovascular diseases. Guiyang Xintian Pharmaceutical Co.,Ltd. was founded in 1995 and is based in Guiyang, China.

Corporate governance

Guiyang Xintian Pharmaceutical Co.,Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.